US President Donald Trump came into office vowing to reduce the cost of prescription drugs for the American consumer. But will that relief come at the expense of pharmaceutical balance sheets? We discuss the implications of US policy for pharma companies with Sam Fazeli of Bloomberg Intelligence.


Image Credit: Shutterstock.com

US President Donald Trump came into office vowing to reduce the cost of prescription drugs for the American consumer. But will that relief come at the expense of pharmaceutical balance sheets? We discuss the implications of US policy for pharma companies with Sam Fazeli of Bloomberg Intelligence. Image Credit: <a target="_blank" rel="noopener noreferrer nofollow" href="http://Shutterstock.com">Shutterstock.com</a>

Opinion and analysis of today’s international and local news that matter to Malaysians. Everything you need to know to start and plan your work.

Opinion and analysis of today&rsquo;s international and local news that matter to Malaysians. Everything you need to know to start and plan your work.

Morning Brief

Big Pharma Relief Over Trump Tariff Reprieve

The WHO has declared the latest Ebola outbreak in the Democratic Republic of Congo and Uganda a global public health emergency, with hundreds of suspected cases linked to the rare Bundibugyo strain. As concerns grow over limited vaccine options and the speed of transmission, what does this outbreak reveal about global preparedness, and how vulnerable are countries like Malaysia to future imported cases?



Image Credit: Shutterstock

The WHO has declared the latest Ebola outbreak in the Democratic Republic of Congo and Uganda a global public health emergency, with hundreds of suspected cases linked to the rare Bundibugyo strain. As concerns grow over limited vaccine options and the speed of transmission, what does this outbreak reveal about global preparedness, and how vulnerable are countries like Malaysia to future imported cases?Image Credit: Shutterstock

Can the World Contain the Latest Ebola Outbreak?

The government’s latest move to open limited public university pathways for UEC graduates has reignited one of Malaysia’s longest-running education debates. While supporters see it as a step towards greater inclusivity, critics argue the policy remains restrictive and politically cautious, raising questions over whether this marks meaningful progress or another temporary compromise in the unresolved issue of UEC recognition.



Image Credit: Shutterstock

The government’s latest move to open limited public university pathways for UEC graduates has reignited one of Malaysia’s longest-running education debates. While supporters see it as a step towards greater inclusivity, critics argue the policy remains restrictive and politically cautious, raising questions over whether this marks meaningful progress or another temporary compromise in the unresolved issue of UEC recognition.Image Credit: Shutterstock

Is Malaysia Finally Moving on UEC Recognition?

The Securities Commission and Bursa Malaysia have proposed allowing retail investors to participate in the LEAP Market, along with other measures to make listing more attractive for SMEs and mid-tier companies. Will these moves revitalize the LEAP Market while maintaining adequate investor protection? We discuss this with Ng Zhu Hann of Tradeview Capital.



Image Credit: Shutterstock

The Securities Commission and Bursa Malaysia have proposed allowing retail investors to participate in the LEAP Market, along with other measures to make listing more attractive for SMEs and mid-tier companies. Will these moves revitalize the LEAP Market while maintaining adequate investor protection? We discuss this with Ng Zhu Hann of Tradeview Capital.Image Credit: Shutterstock

Big Pharma Relief Over Trump Tariff Reprieve

In 1 playlist(s)

Morning Brief

Social links

Follow podcast

Recent clips